Long-term antigen reduction does not achieve durable HBV control in mice but enhances therapeutic vaccine efficacy. - Michler T; Kosinska A; Merdan O; Hagen P; Bunse T; Öz EA; Su J; Busch DH; Mogler C; Protzer U (JHEP reports : innovation in hepatology, 2026)